ADC Therapeutics Licenses Proprietary Antibodies from Five Prime ... PharmiWeb.com (press release) Under the agreement ADC Therapeutics plans to initiate preclinical research and development of antibody-drug conjugates using the antibodies licensed from Five Prime immediately adding to ADC Therapeutics’ portfolio of proprietary ADC programs. |
